The HALOPV 6.0 webinar on December 5, 2024, showcased the platform’s latest features, designed to enhance case processing and global compliance through cutting-edge AI-driven solutions. The event included a comprehensive agenda covering the latest features, demonstrations, and upcoming innovations in HALOPV. It concluded with a Q&A session to address participant queries.
Key Highlights
New Functionalities Demonstrated
-
Case Intake Enhancements: AI-powered text extraction and improved workflows.
-
Multi-lingual Capabilities: Support for global compliance with field masking, auto-translation, and redaction.
-
Side-by-Side Screens: Streamlined document annotation and review processes.
-
Coding & Dictionary Management: Enhanced CMQ/term grouping, IDF Japan coding support, and signal detection integration.
Upcoming 6.1 Features
-
Greater configurability for case intake forms.
-
Advanced AI functionalities for text and data handling.
Literature Module
-
Streamlined search string creation and integration with PUBMED for fetching articles and auto-creating ICSRs.
HALOPV Demo
-
A live demonstration highlighted practical applications of the features and their impact on pharmacovigilance workflows.
Speakers
Louise Tan, Principal PV Consultant and Head of GRIP Services
Louise is a PV subject matter expert with 15+ years of experience within Industry, consulting, PV network leadership and project management, combining deep domain knowledge with strong presentation, facilitation and problem-solving skills. She joined Insife in December 2022 with an aim to expand her horizons in the PV tech ecosystem and works with both Industry and Regulators to implement game changing technologies. Louise currently leads our Global Regulatory Intelligence Club for Pharmacovigilance (GRIP).
Martin Holm-Petersen, CEO
Executive leader with 10 years of experience within the pharma industry and another 10+ years in consulting. Martin is an experienced manager and strategist, with understanding across the pharma business value chain, and an expert on Pharmacovigilance. His current role is CEO of Insife, a global technology and consulting company. In this capacity, digital transformation is central to Martin’s engagements with Industry and Regulatory Agencies.
The upcoming online event will delve into topics of innovation in case intake, exploring the different approaches to technology, featuring insights from industry experts, and examining the integration of AI within intake processes and the diverse approaches to tackling this challenge.